Gaygisiz, Ü. Et Al. 2016. Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?. Scandinavian journal of clinical and laboratory investigation , vol.76, no.2 , 143-50.

Gaygisiz, Ü., AYDOĞDU, M., Badoglu, M., Boyaci, N., Gullu, Z., & GÜRSEL, G., (2016). Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?. Scandinavian journal of clinical and laboratory investigation , vol.76, no.2, 143-50.

Gaygisiz, ÜMMÜGÜLSÜM Et Al. "Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?," Scandinavian journal of clinical and laboratory investigation , vol.76, no.2, 143-50, 2016

Gaygisiz, ÜMMÜGÜLSÜM Et Al. "Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?." Scandinavian journal of clinical and laboratory investigation , vol.76, no.2, pp.143-50, 2016

Gaygisiz, Ü. Et Al. (2016) . "Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?." Scandinavian journal of clinical and laboratory investigation , vol.76, no.2, pp.143-50.

@article{article, author={ÜMMÜGÜLSÜM GAYGISIZ Et Al. }, title={Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?}, journal={Scandinavian journal of clinical and laboratory investigation}, year=2016, pages={143-50} }